Cell banking.

  • Wiebe M
  • May L
  • 6

    Readers

    Mendeley users who have this article in their library.
  • 13

    Citations

    Citations of this article.

Abstract

The use of cultured cells (diploid strains or continuous cell lines) to produce biopharmaceuticals provides a level of standardization to the manufacturing process that cannot be attained by the more traditional methods of biological extraction from animal or human fluids, tissues, or primary cells. The key to this advantage is the ability to cryopreserve the production cell line as a master cell bank. This bank serves as the common starting source of a given product for the lifetime of the manufacture of that product. Since the MCB is the common and only starting source, it can be exhaustively characterized with regard to contamination by adventitious and endogenous agents. Assays can be developed for cellular components that are potential contaminants of the product. The removal of these components during product purification can be validated and their removal confirmed by rigorous quality control. In conclusion, characterized cell banks are central to the standardization of biopharmaceutical manufacturing processes and give rise to the production of high-quality products not attainable by the traditional methods of extraction of product from sources which are continually changing.

Author-supplied keywords

  • Animals
  • Biotechnology
  • Cell Line
  • Cells, Cultured
  • Culture Techniques
  • Genetic Engineering
  • Humans
  • methods

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • SGR: 0025579484
  • PUI: 21823186
  • SCOPUS: 2-s2.0-0025579484
  • ISSN: 0888-7470 (Print)
  • PMID: 1367056

Authors

  • M E Wiebe

  • L H May

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free